Robert Morgan

Learn More
Supporting agile teams from afar as they plan projects is a challenge. In this paper, we present a planning tool, MasePlanner, which supports agile teams as they collaborate in a distributed environment during their planning meetings. Combined with an audio link, our tool supports natural interaction similar to those found in collocated agile planning(More)
Computer-supported environments for agile project planning are often limited by the capability of the hardware to support collaborative work. We present DAP, a tool developed to aid distributed and collocated teams in agile planning meetings. Designed with a multi-client architecture, it works on standard desktop computers and digital tables. Using digital(More)
Documenting the recovery of hydrologic functions following perturbations is important to addressing issues associated with land use change and ecosystem restoration. Floodplains on the Santee Experimental Forest were used historically for rice cultivation in the early 1700s; those areas now support bottomland hardwood forests typical of the region. Recently(More)
Providing support for distributed agile teams as they conduct planning meetings is tricky. In distributed settings, the use of paper index cards for planning isn't convenient, as some of the team members do not have access to the physical cards. We present the results of an observational study where a distributed card based planning tool was evaluated(More)
Agile project planning plays an important part in agile software development. In distributed settings, project planning is severely impacted by the lack of face-to-face communication and the inability to share paper index cards amongst all meeting participants. To address these issues, several distributed agile planning tools were developed. The tools vary(More)
Nanoparticle-based experimental therapeutics are currently being investigated in numerous human clinical trials. CALAA-01 is a targeted, polymer-based nanoparticle containing small interfering RNA (siRNA) and, to our knowledge, was the first RNA interference (RNAi)-based, experimental therapeutic to be administered to cancer patients. Here, we report the(More)
Ovarian cancer is a common cause of cancer mortality in women with limited treatment effectiveness in advanced stages. The limitation to treatment is largely the result of high rates of cancer recurrence despite chemotherapy and eventual resistance to existing chemotherapeutic agents. The objective of this paper is to review current concepts of ovarian(More)
Changing healthcare policy will undoubtedly affect the healthcare environment in which providers function. The current Fee for Service reimbursement model will be replaced by Value-Based Purchasing, where higher quality and more efficient care will be emphasized. Because of this, large healthcare organizations and individual providers must adapt to(More)